title: [Characteristics of arrhythmias and their treatment with diltiazem in patients with bronchial asthma].
abstract: The authors' studies demonstrate that 87.5% of patients with exacerbation of moderate bronchial asthma have cardiac arrhythmias most of which have favorable prognosis. Most of the arrhythmias were supraventricular. Hypercatecholaminemia is considered one of the mechanisms contributing to development of arrhythmia in bronchial asthma exacerbation. Administration of diltiazem proved that this drug is highly effective in the treatment of both supraventricular and ventricular arrhythmias in asthma patients.
authors.forename: V B
authors.initials: VB
authors.lastname: Simonenko
authors.forename: S A
authors.initials: SA
authors.lastname: Boĭtsov
authors.forename: A N
authors.initials: AN
authors.lastname: Kuchmin
authors.forename: K Iu
authors.initials: KIu
authors.lastname: Nedoshvin
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D001249:Asthma / Q000150:complications*; D004110:Diltiazem / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006339:Heart Rate / Q000502:physiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index
chemical_list: D000959:Antihypertensive Agents; D004110:Diltiazem